Endure to Cure Pediatric Cancer Foundation

EIN: 452861060 501(c)(3) Medical Research

Wilmington, DE

Total Revenue
$360,882
Total Expenses
$395,112
Total Assets
$8,030
Net Assets
$-46,220
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2011
Legal Domicile
DE
Principal Officer
Jason Sissel
Phone
8664002121
Tax Period
2024-01-01 to 2024-12-31

Endure to Cure Pediatric Cancer Foundation, founded in 2011, is a small nonprofit in the Medical Research sector that reported $361K in total revenue in fiscal year 2024. Revenue surged 24% from the prior year, signaling strong growth momentum.

Mission

Provide aid to pediatric cancer patients.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $360,882
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $360,882

Expense Breakdown

Grants Paid $159,214
Salaries & Benefits $0
Fundraising Expenses $93,955
Program Expenses $235,560
Other Expenses $235,898
TOTAL EXPENSES $395,112

Year-over-Year Comparison

2024 2023 Change
Revenue $360,882 $290,797 +0.2%
Expenses $395,112 $325,337 +0.2%
Net Income $-34,230 $-34,540 0.0%
Key Indicators
✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
5
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$0
Total Directors
4
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Jason Sissel CEO 4.00
Officer Director
$0 $0 $0
Loukas Stephens Treasurer 1.00
Officer Director
$0 $0 $0
Amanda Burrill Director 1.00
Director
$0 $0 $0
Ismail Amin Director 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $360,882 $395,112 $8,030 $-34,230
2023 $290,797 $325,337 $12,260 $-34,540
2022 $250,149 $229,150 $6,800 $20,999
2019 $286,815 $278,526 $8,289 $8,289
2018 $212,035 $194,681 $31,701 $17,354
Explore More Nonprofits
→Top 100 Nonprofits in Delaware →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare Endure to Cure Pediatric Cancer Foundation with other nonprofits in Delaware and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.